A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Single agent of cyclophosphamide, doxorubicin, epirubicin, fluorouracil and methotrexate|DRUG: cyclophosphamide, doxorubicin, epirubicin, fluorouracil and methotrexate (CDEFM)|DRUG: Placebo
Sponsor: Shanghai Jiao Tong University School of Medicine
Collaborators: Shanghai 10th People's Hospital|China-Japan Union Hospital, Jilin University|Ganzhou City People's Hospital